Provided by Tiger Trade Technology Pte. Ltd.

Beyond Air, Inc.

1.15
-0.1300-10.16%
Post-market: 1.230.0800+6.96%19:49 EST
Volume:147.92K
Turnover:179.59K
Market Cap:9.21M
PE:-0.16
High:1.31
Open:1.30
Low:1.13
Close:1.28
52wk High:11.20
52wk Low:1.00
Shares:8.01M
Float Shares:4.13M
Volume Ratio:1.04
T/O Rate:3.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.2420
EPS(LYR):-13.7727
ROE:-178.02%
ROA:-49.72%
PB:0.72
PE(LYR):-0.08

Loading ...

Company Profile

Company Name:
Beyond Air, Inc.
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
61
Office Location:
900 Stewart Avenue,Suite 301,Garden City,New York,United States
Zip Code:
11530
Fax:
- -
Introduction:
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Directors

Name
Position
Steven A. Lisi
Chief Executive Officer, Chairman of the Board and Director
Amir Avniel
President, Chief Business Officer and Director
Erick Lucera
Director
Robert F. Carey
Director
Robert S. Goodman
Director
William Forbes
Director
Yoori Lee
Director

Shareholders

Name
Position
Steven A. Lisi
Chief Executive Officer, Chairman of the Board and Director
Michael Gaul
Chief Operating Officer
Amir Avniel
President, Chief Business Officer and Director